pMH-MYC Citations (4)

Originally described in: Dual-utility NLS drives RNF169-dependent DNA damage responses.
An L, Jiang Y, Ng HH, Man EP, Chen J, Khoo US, Gong Q, Huen MS Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2872-E2881. doi: 10.1073/pnas.1616602114. Epub 2017 Mar 21. PubMed Journal

---

Articles Citing pMH-MYC

Articles
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer. Burr ML, Sparbier CE, Chan KL, Chan YC, Kersbergen A, Lam EYN, Azidis-Yates E, Vassiliadis D, Bell CC, Gilan O, Jackson S, Tan L, Wong SQ, Hollizeck S, Michalak EM, Siddle HV, McCabe MT, Prinjha RK, Guerra GR, Solomon BJ, Sandhu S, Dawson SJ, Beavis PA, Tothill RW, Cullinane C, Lehner PJ, Sutherland KD, Dawson MA. Cancer Cell. 2019 Oct 14;36(4):385-401.e8. doi: 10.1016/j.ccell.2019.08.008. Epub 2019 Sep 26. PubMed
DUB3 is a MAGEA3 deubiquitinase and a potential therapeutic target in hepatocellular carcinoma. Chen Y, Gao F, He Y, Liu M, Quan Y, Zhang P. iScience. 2024 Feb 8;27(3):109181. doi: 10.1016/j.isci.2024.109181. eCollection 2024 Mar 15. PubMed
USP26 as a hepatitis B virus-induced deubiquitinase primes hepatocellular carcinogenesis by epigenetic remodeling. Ma M, Yi L, Pei Y, Zhang Q, Tong C, Zhao M, Chen Y, Zhu J, Zhang W, Yao F, Yang P, Zhang P. Nat Commun. 2024 Sep 9;15(1):7856. doi: 10.1038/s41467-024-52201-z. PubMed
Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders. Zhou H, Balint D, Shi Q, Vartanian T, Kriegel MA, Brito I. Ann Rheum Dis. 2025 Jan;84(1):93-105. doi: 10.1136/ard-2024-225829. Epub 2025 Jan 2. PubMed

If you have published an article using this material, please email us at to have your article added to this page.